The American Medical Association Statement on CDC’s Updated Mask Guidance to Combat Spread of COVID-19

Community NewsPublisher's Picks
209

Translate to Spanish or other 102 languages!

Image for illustration purposes.

Mega Doctor News

- Advertisement -

By Dr. Gerald E. Harmon

Gerald E. Harmon, M.D.
President, American Medical Association

“With cases of COVID-19 continuing to increase in the United States and a significant number of people who remain unvaccinated, the CDC’s updated mask guidance is needed to help curb the spread of COVID-19—particularly the Delta variant, which we know is much more contagious.

According to the CDC, emerging data indicates that vaccinated individuals infected with the Delta variant have similar viral loads as those who are unvaccinated and are capable of transmission. However, the science remains clear, the authorized vaccines remain safe and effective in preventing severe complications from COVID-19, including hospitalization and death. “We strongly support the updated recommendations, which call for universal masking in areas of high or substantial COVID-19 transmission and in K-12 schools, to help reduce transmission of the virus. Wearing a mask is a small, but important protective measure that can help us all stay safer.

- Advertisement -

“The AMA continues to strongly encourage everyone who is eligible for COVID-19 vaccines to get vaccinated as soon as possible. We urge anyone with questions about the vaccines to speak with their physician and review trusted resources, including getvaccineanswers.org.” 

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Tips for Mindful Eating at the Office
Next article
“On a crash course”: Texas hospitals brace for another COVID-19 surge as delta variant burns through unvaccinated communities

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

DHR Health Expands Ophthalmology Services with Addition of Dr. Rachel Gelman

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.

STHS McAllen Welcomes Aspiring Youth for an Interactive Look Inside Healthcare

As the demand for healthcare professionals continues to grow, introducing young students to the wide range of opportunities available in the medical field is more important than ever. From nurses and physicians to emergency responders, pharmacists and other essential healthcare workers, each plays a critical role in caring for patients and keeping communities healthy.

South Texas Health System Invests $25,000 in VIDA to Expand Healthcare Career Opportunities in the RGV

To help address the ongoing need for qualified workers in the Rio Grande Valley, South Texas Health System (STHS) has renewed its support of Valley Initiative for Development and Advancement (VIDA) through a $25,000 annual grant.
- Advertisement -